Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Naredi

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Protein and Peptide Letters|August 31, 2013
Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cellsMaria E Palm-Espling, Christina Lundin, Erik Björn, et al.
Cancer Biomarkers : Section a of Disease Markers|December 20, 2014
Combining conventional and stroma-derived tumour markers in pancreatic ductal adenocarcinomaOskar Franklin, Daniel Öhlund, Christina Lundin, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2021
Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinomaMikael Öman, Yvonne Wettergren, Elisabeth Odin, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|September 11, 2012
Non-invasive identification of melanoma with near-infrared and skin impedance spectroscopyIda Bodén, Josefina Nyström, Bertil Lundskog, et al.
Surgical Oncology|July 22, 2008
Recommended core curriculum for the specialist training in surgical oncology within EuropePeter Naredi, Marjut Leidenius, Marko Hocevar, et al.
Analytical Biochemistry|February 9, 2007
Determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometryErik Björn, Yvonne Nygren, Tam Trinh Thi Nhu Nguyen, et al.
Scientific Reports|April 22, 2021
Alternative redox forms of ASNA-1 separate insulin signaling from tail-anchored protein targeting and cisplatin resistance in C. elegansDorota Raj, Ola Billing, Agnieszka Podraza-Farhanieh, et al.
Oncology Letters|June 13, 2019
EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survivalJohan Bourghardt Fagman, David Ljungman, Peter Falk, et al.
Anticancer Research|April 12, 2003
Immune response in blood and tumour tissue in patients with metastatic malignant melanoma treated with IL-2, IFN alpha and histamine dihydrochlorideAndreas Schjellerup Jørkov, Frede Donskov, Torben Steiniche, et al.
Melanoma Research|June 5, 2003
Treatment with histamine dihydrochloride and interleukin-2 in patients with advanced metastatic malignant melanoma: a detailed safety analysisSteven J O'Day, Sanjiv S Agarwala, Peter Naredi, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Protein and Peptide Letters|August 31, 2013
Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cellsMaria E Palm-Espling, Christina Lundin, Erik Björn, et al.
Cancer Biomarkers : Section a of Disease Markers|December 20, 2014
Combining conventional and stroma-derived tumour markers in pancreatic ductal adenocarcinomaOskar Franklin, Daniel Öhlund, Christina Lundin, et al.
Cancer Chemotherapy and Pharmacology|June 16, 2021
Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinomaMikael Öman, Yvonne Wettergren, Elisabeth Odin, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|September 11, 2012
Non-invasive identification of melanoma with near-infrared and skin impedance spectroscopyIda Bodén, Josefina Nyström, Bertil Lundskog, et al.
Surgical Oncology|July 22, 2008
Recommended core curriculum for the specialist training in surgical oncology within EuropePeter Naredi, Marjut Leidenius, Marko Hocevar, et al.
Analytical Biochemistry|February 9, 2007
Determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometryErik Björn, Yvonne Nygren, Tam Trinh Thi Nhu Nguyen, et al.
Scientific Reports|April 22, 2021
Alternative redox forms of ASNA-1 separate insulin signaling from tail-anchored protein targeting and cisplatin resistance in C. elegansDorota Raj, Ola Billing, Agnieszka Podraza-Farhanieh, et al.
Oncology Letters|June 13, 2019
EGFR, but not COX-2, protein in resected pancreatic ductal adenocarcinoma is associated with poor survivalJohan Bourghardt Fagman, David Ljungman, Peter Falk, et al.
Anticancer Research|April 12, 2003
Immune response in blood and tumour tissue in patients with metastatic malignant melanoma treated with IL-2, IFN alpha and histamine dihydrochlorideAndreas Schjellerup Jørkov, Frede Donskov, Torben Steiniche, et al.
Melanoma Research|June 5, 2003
Treatment with histamine dihydrochloride and interleukin-2 in patients with advanced metastatic malignant melanoma: a detailed safety analysisSteven J O'Day, Sanjiv S Agarwala, Peter Naredi, et al.
Pageof 10